Marc-Henri Stern received his doctorate in medicine and his PhD in Sciences (immunology) from the universities of Paris. After his postdoctoral training at N.C.I. (USA), he began his research team at Saint Louis Hospital, Paris, on leukemogenesis and DNA repair defects.
He joined the Curie Institute in 2000, setting up his team in the Inserm unit U830 unit led by Dr. Olivier Delattre, maintaining a medical activity within the Oncogenetics unit led by Prof. Dominique Stoppa-Lyonnet. His team is dedicated to unravel the genetic factors of tumor predisposition and of oncogenesis in adult tumors, including breast and ovarian carcinomas and uveal melanoma, ranging from fundamental and translational research to diagnosis.